Impact of Demographics, Organ Impairment, Disease, Formulation, and Food on the Pharmacokinetics of the Selective S1P1 Receptor Modulator Ponesimod Based on 13 Clinical Studies. Lott D, Lehr T, Dingemanse J, Krause A Clin Pharmacokinet. 2016 Sep 15. PMID: 27638335. Abstract CommentRecommendBookmarkWatch